IN VITRO STUDIES IN DRUG DISCOVERY AND DEVELOPMENT: AN ANALYSIS OF STUDY OBJECTIVES AND APPLICATION OF GOOD LABORATORY PRACTICES (GLP)
- 1 January 2002
- journal article
- review article
- Published by Taylor & Francis in Drug Metabolism Reviews
- Vol. 34 (4) , 679-689
- https://doi.org/10.1081/dmr-120015690
Abstract
In vitro drug metabolism studies play a dual role along the path from drug discovery to preclinical development. By analyzing the objectives of each type of study the question of whether to apply good laboratory practices (GLP) requirements is clarified. This review outlines the various in vitro techniques available and categorizes the goals for which they are applied as either supporting drug discovery or influencing decisions of clinical safety. Based on this categorization it is proposed that studies performed to explore the utility of a potential drug candidate be conducted non-GLP, while studies used to support IND and post-IND submissions be considered for GLP.Keywords
This publication has 32 references indexed in Scilit:
- High-throughput Caco-2 cell permeability screening by cassette dosing and sample pooling approaches using direct injection/on-line guard cartridge extraction/tandem mass spectrometryRapid Communications in Mass Spectrometry, 2000
- In vitro metabolic interaction studies: Experience of the Food and Drug AdministrationClinical Pharmacology & Therapeutics, 1999
- Automated absorption assessment using Caco-2 cells cultured on both sides of polycarbonate membranes.Pharmaceutical Research, 1999
- MDCK (Madin-Darby Canine Kidney) Cells: A Tool for Membrane Permeability ScreeningJournal of Pharmaceutical Sciences, 1999
- P-Glycoprotein (P-gp) Mediated Efflux in Caco-2 Cell Monolayers: The Influence of Culturing Conditions and Drug Exposure on P-gp Expression LevelsJournal of Pharmaceutical Sciences, 1998
- Expression of Enzymatically Active CYP3A4 by Caco-2 Cells Grown on Extracellular Matrix-Coated Permeable Supports in the Presence of 1α,25-Dihydroxyvitamin D3Molecular Pharmacology, 1997
- Intestinal Absorption Screening of Mixtures from Combinatorial Libraries in the Caco-2 ModelPharmaceutical Research, 1997
- Evaluation of Biocoat® Intestinal Epithelium Differentiation Environment (3-Day Cultured Caco-2 Cells) as an Absorption Screening Model with Improved ProductivityPharmaceutical Research, 1997
- Ranking of P-glycoprotein substrates and inhibitors by a calcein-AM fluorometry screening assayAnti-Cancer Drugs, 1996
- Correlation between oral drug absorption in humans and apparent drug permeability coefficients in human intestinal epithelial (Caco-2) cellsBiochemical and Biophysical Research Communications, 1991